| Metric | შპს SmartPharm | სს საქართველოს ნავთობისა და გაზის კორპორაცია |
|---|---|---|
| Growth | ||
| Revenue | ₾36.6m₾31.6m | ₾1.65bn₾1.40bn |
| Revenue growth | 15.9% | 17.4% |
| Profitability | ||
| EBITDA | ₾2.0m₾3.3m | ₾247.6m₾130.7m |
| EBITDA margin | 5.4%10.4% | 15.0%9.3% |
| Net profit | ₾1.9m₾2.8m | ₾183.4m₾50.1m |
| Net margin | 5.2%8.8% | 11.1%3.6% |
| Balance sheet | ||
| Total assets | ₾16.6m₾13.4m | ₾2.19bn₾2.04bn |
| Total equity | ₾13.1m₾11.6m | ₾1.32bn₾1.14bn |
| ROE | 14.5%23.9% | 13.9%4.4% |